NPS+ Asthma/COPD (EU5)

NPS+ Asthma/COPD (EU5)

Code: FW-21072016-32 | Published: May-2016 | Pages: 0 | FirstWord
Price :

* Required Fields



Satisfaction survey: One brand dominates EU5 Asthma/COPD market. Can your brand compete?

Which asthma/COPD brand scored twice as high as its closest competitor (and nearly five times as high as the 3rd place brand) in a recent satisfaction survey? How does your brand measure up? Do doctors prefer fixed-dose combinations to single agent therapies? Get our new report and find out.

This report compares brand loyalty for 9 major Asthma/COPD treatments from AstraZeneca, Boehringer, GSK, Novartis and Roche.

Based on the respected net promoter score (NPS), it shows you:

How likely doctors are to recommend your brand—and your competitors.

Which marketing messages are likely to succeed.

Your “Brand DNA”: What doctors really think about your brand.

Easy-to-use KPIs highlight areas for improvement and make your next steps crystal clear—information you can use to improve your brand’s health, and boost your market share.

Get Answers to Key Questions about Asthma/COPD Treatments

Daxas (roflumilast): Could concerns about weight loss and GI side effects be preventing Detractors from recommending Daxas?
Eklira (aclidinium; AstraZeneca): Cost effectiveness is the #1 driver of doctor recommendations for two brands. Is Eklira one of them?
Nucala (mepolizumab; GSK): One brand message resonates with high numbers of Nucala Promoters Detractors and Passives. What is it?
Onbrez (indacaterol; Novartis): Which brand stands to gain more market share by winning over detractors, Onbrez or Eklira?
Relvar Ellipta (fluticasone furoate /vilanterol; GSK): Are Relvar Ellipta’s Passives closer to becoming Promoters or Detractors?
Seretide (fluticasone propionate/salmeterol; GSK): Seretide and Symbicort have nearly equal numbers of Promoters. Which brand has the higher NPS?
Spiriva (tiotropium; Boehringer): What other drug (not covered in this report) did one Detractor say they preferred to Spiriva?
Symbicort (budesonide/formoterol; AstraZeneca): Are issues with its inhaler preventing some Detractors from recommending Symbicort?
Xolair (omalizumab; Novartis/Roche): For which patient population do Promoters and Detractors say Xolair is most effective?

Top Takeaways

One brand dominates: Four of nine brands have positive scores, but the leading brand scores two-and-a-half times as high as its closest competitor.
FDCs doing well: Fixed-dose combination therapies tend to outscore monotherapies overall, earning 3 of the top 4 Net Promoter Scores.
8/9 brands poised for massive market share gain: if they can win over their Detractors and turn them into Promoters.
Moderate satisfaction, low exclusivity: nearly 35% of doctors surveyed are unsatisfied with available asthma/COPD drugs. Less than 15% promote one brand exclusively.
High numbers of “Passives”: More than in the US market. On average, nearly 40% of doctors surveyed are neither Promoters nor Detractors of the brands surveyed.
Doctors switch brands freely: Promoters of each brand promote more than 4 others on average. Detractors promote nearly all of the other surveyed brands.
Cost a concern for two brands: For two fixed-dose combinations, cost effectiveness drives the most doctor recommendations.
Leading brands are the same in US, EU5: Although the rankings are slightly different, the same four brands earn the highest satisfaction scores in both regions.

A Report Based on Expert Knowledge

We surveyed 150 pulmonologists and general practitioners from the EU5 (France, Italy, Germany, Spain, UK), chosen from the largest community of validated physicians in the world. The same community that pharma market researchers trust for reliable, fast intelligence.

We conducted the survey between April 7th and April 14th, 2016.

Explore Important Brand Loyalty Issues

NPS+ asthma/COPD (EU5) explores key issues affecting brand loyalty for drug manufacturers. You’ll learn:

How satisfied the asthma/COPD market is.
How loyal doctors are to your brand.
How many other brands your Promoters recommend.
Which other brands your Promoters and Detractors recommend.
How much market share your brand has among Promoters and Detractors.
How much market share you stand to gain by converting Detractors into Promoters.
Which messages Promoters, Passives and Detractors associate with your brand.
Your brand DNA: what doctors really think of your brand—in their own words.

What is Net Promoter® Score?
NPS is a customer loyalty metric developed by (and a registered trademark of) Fred Reichheld, Bain & Company, and Satmetrix. It was introduced by Reichheld in his 2003 Harvard Business Review article One Number You Need to Grow.

How does NPS work?
NPS measures overall brand satisfaction and loyalty by asking one simple question:

""How likely are you to recommend this brand to a colleague?""

Responses - given on a scale of 0 (not at all likely) to 10 (extremely likely)—are used to classify respondents into 3 categories:

Detractors are those who answer 0 – 6.
Passives are those who answer 7 – 8.
Promoters are those who answer 9 - 10.

How is NPS calculated?
The percentage of detractors - the percentage of promoters = NPS.
For example, 25% Promoters, 55% Passives and 20% Detractors give you an NPS of +5.
NPS can range from -100 (everybody is a Detractor) to +100 (everybody is a Promoter). The higher the score the healthier the brand.

What is FirstView NPS+?

NPS+ turns your Net Promoter Score into actionable information by answering key questions about brand loyalty.

Each NPS+ report examines doctors’ relationships with the brands used to treat a major disease area—measuring brand loyalty and showing you how it affects your market share. NPS+ also examines “brand DNA”, revealing in doctors’ own words what brands mean to them.

Instead of one simple metric, NPS+ gives you a detailed picture of brand health that highlights areas for improvement, and helps you see exactly what steps you need to take next.

Money Back Guarantee!
At FirstWord, we stand behind our reports. If you're not completely satisfied, we’ll refund your money. Guaranteed.

Table of Contents

1.Chart 1: Net Promoter Score?
2.Chart 2: How loyal are doctors to my brand?
3.Chart 3: How satisfied is the market?
4.Chart 4: How many other brands are promoted by my Promoters?
5.Chart 5: Which other brand is most promoted by my Promoters?
6.Chart 6: Which other brands are promoted by my Detractors?
7.Chart 7: What is my brand's market share among Promoters and Detractors?
8.Chart 8: What brand messages are associated with Promoters, Passives and Detractors (by
9.Chart 9: What does my brand represent to Promoters and Detractors (by brand)?

Report Format

Following are different modes of Licenses.

a. Single User License:
This license allows only one person to use the report. This person can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people. Unless you purchase a Site License or a Global Site License, a Single User License must be purchased for every single person that wishes to use the report within the same enterprise.

b. Single Site License:
This license allows unlimited users to use the report within one company location, e.g. a regional office. These users can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people.

c. Global Site License:
A Global Site License (or Enterprise wide Site License or Global License) is a license granted to original purchaser, who can share a report with other employees and authorized Users of the same organization.

Quick Help

1. How do you deliver the reports?
The delivery of reports is depends on format & mode of license of report(s). Following are different kinds of formats of report(s) and their delivery options :

a. Electronic Format – Through email from Publisher
Report will be sent to your username email address in PDF, Excel, PowerPoint or any other electronic / softcopy format by publisher.
Delivery Time: 12 to 48 hours [depending on time difference or occurrences of national holidays]

b. Hard Copy or Printed Format or CD-Rom – Through Mail or Courier from Publisher
Report will be sent through mail / courier delivery to your shipping address by publisher.
Delivery Time: Less than, few weeks [depending on time difference or occurrences of national holidays]

2. How can I make payment for publications I purchase?
You could be able to make the payment, in following ways:

a. Online Secure Payment through Credit Card Payment : We accept Visa, Master, AMEX Cards & CCAvenue
b. Transfer of fund to our bank account via Bank transfer or Wire transfer
c. Payment via DD or Cheque
d. Paypal

3. Is it safe to use my credit card on MarketinfoResearch?
Your personal information and online tranaction on Marketinfo Research is secure, private, and tamper-proof. All credit card payments are processed through secure and trusted payment gateways.

If you have a more question about our publications please see our FAQs section or contact us now at

Browse similar reports by category:
Pharmaceuticals & Healthcare

Our Clients